 Avid Bioservices, Inc. CDMO CDMOP, a dedicated biologics contract development and manufacturing organization CDMO working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced that it has signed two new contract manufacturing service agreements to support the development of novel drug candidates. The agreements include the addition of one the worlds top ten pharmaceutical companies by revenue to Avids growing list of customers, as well as the expansion of the relationship with one of the companys existing biotechnology customers. Under terms of the first agreement, Avid will provide process transfer and clinical manufacturing services to the large pharmaceutical company to support development of a novel therapeutic candidate. Avid and its client will immediately commence process transfer of cell line and bench scale information for the program, followed by initiation of 2000 liter CGMP clinical manufacture of the compound. 